Eric Roselli, MD

Appointed
2005

Education & Fellowships

Residency - Cleveland Clinic
Thoracic Surgery
Cleveland, OH
2005

Residency - Cleveland Clinic
General Surgery
Cleveland, OH
2002

Internship - Cleveland Clinic
General Surgery
Cleveland, OH
1998

Medical Education - Loyola University Stritch School of Medicine
Chicago, IL
1997

Undergraduate - University of Michigan
Science/Philosophy
Ann Arbor, MI
1993

Additional Training

• Endovascular Surgery Fellowship, Cleveland Clinic

Certifications

• Thoracic Surgery - Thoracic and Cardiac Surgery

Specialty Interests

Adult Cardiac surgery, surgery for thoracic aortic aneurysm and dissection including endovascular treatment, Aortic valve repair and replacement including minimally invasive and percutaneous treatment, high-risk reoperation surgery, aortic related congenital issues, and surgery for cardiovascular tumors

Awards & Honors

• 2015: Thoracic Surgery Residents Association Dwight C McGoon National Teaching Award
• 2015; Sones Favaloro Award for Disease Centers and IPU Development
• 2008, 2011: Bruce W. Lytle Master Clinical Instructor Award (Teacher of the Year)
• 2005:  Dr. Charles H. Bryan Annual Award for Clinical Excellence in Thoracic and Cardiovascular Surgery, Cleveland Clinic

Innovations & Patents

• Dr. Roselli is one of only a few "hybrid" specialists trained in both open surgical and interventional techniques for the treatment of complex structural heart (aortic and mitral valve) and thoracic aortic disease (aneurysms and dissection).   He has been instrumental in the development of several new less invasive approaches used to treat complex cardiovascular disease.

See publications for Eric Roselli, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/15/2024, Dr. Roselli has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Roselli receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Artivion, Inc., formerly CryoLife, Inc./ Jotec
• W.L. Gore and Associates, Inc
• Edwards Lifesciences LLC

Royalty Payments. Dr. Roselli receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

• Artivion, Inc., formerly CryoLife, Inc./ Jotec

Right to Future Distribution of Cleveland Clinic Financial Interest. Dr. Roselli may receive future financial benefits from the Cleveland Clinic for inventions or discoveries commercialized through the companies shown below:

• Artivion, Inc., formerly CryoLife, Inc./ Jotec

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.